September 2026 marked Childhood Cancer Awareness Month, also known as Gold September, raising awareness of the challenges faced by children and adolescents with cancer, survivors and their families. In 2026, Childhood Cancer International and the International Society of Paediatric Oncology invited communities to “Turn the World Gold”, highlighting solidarity and the inequalities that continue to affect access to care and survival. Learn more about the 2026 campaign.
GLIOMATCH contributes to research into paediatric high-grade gliomas, rare and aggressive brain tumours affecting children. Its paediatric study brings together teams from University Hospitals Leuven, Uppsala University and Sant Joan de Déu in Barcelona. By analysing archived tumour samples alongside clinical data, the teams aim to better understand tumour biology and generate knowledge to support the development of future treatments.
In honour of this month, and to join the movement, we have compiled relevant GLIOMATCH resources.
Relevant articles
- Julie Morscio’s research presentation at SIOPE BTG 2026: Read Julie’s testimonial about investigating radiotherapy resistance in paediatric diffuse midline glioma using patient tissue and laboratory-grown tumour models.
- GLIOMATCH: Explained with Prof. Dr. Sandra Jacobs: Discover the paediatric study, its participating centres and the challenges of working with small, archived tumour samples in this written intervbiew with Sandra.
- Our International Childhood Cancer Day feature: Explore why dedicated paediatric glioma research matters, including Sandra Jacobs’ contribution to the GBM Podcast.
- About Sant Joan de Déu Barcelona Children’s Hospital: Discover the hospital’s expertise in paediatric cancer care and research, and meet its team in our article about GLIOMATCH’s fifth consortium meeting in Barcelona.
